Gene · 1672
Papers3,189
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,189
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Resveratrol Has Histone 4 and Beta-Defensin 1-Mediated Favorable Biotherapeutic Effects on Liver and Other Target Organs in Diabetic Rats. | Turk J Gastroenterol | 2024 | 39128051 | PubTator, text mining | PubMed |
| Defensins: Exploring Their Opposing Roles in Colorectal Cancer Progression. | Cancers (Basel) | 2024 | 39123348 | PubTator, text mining | PubMed |
| Human β-defensin-1 activates autophagy in human colon cancer cells via regulation of long non-coding RNA TCONS_00014506. | World J Gastrointest Oncol | 2024 | 39072156 | PubTator, text mining | PubMed |
| Probing Protein-Ligand Methyl-π Interaction Geometries through Chemical Shift Measurements of Selectively Labeled Methyl Groups. | J Med Chem | 2024 | 39069741 | PubTator, text mining | PubMed |
| Materials derived from the human elastin-like polypeptide fusion with an antimicrobial peptide strongly promote cell adhesion. | J Mater Chem B | 2024 | 39045800 | PubTator, text mining | PubMed |
| Comparison of salivary beta-defensin-1 levels in patients with periodontitis before and after phase I periodontal therapy. | J Adv Periodontol Implant Dent | 2024 | 39027207 | PubTator, text mining | PubMed |
| The DEFB1 gene rs11362 A/G genetic variant is associated with risk of developing CAD: a case-control study. | Acta Cardiol | 2024 | 38973431 | PubTator, text mining | PubMed |
| Identification of immune-associated biomarkers of diabetes nephropathy tubulointerstitial injury based on machine learning: a bioinformatics multi-chip integrated analysis. | BioData Min | 2024 | 38951833 | PubTator, text mining | PubMed |
| Discovery of a potent orally available pyrazolopyridone derivative as a novel selective bromodomain and extra-terminal domain (BET)-first bromodomain (BD1) inhibitor. | Bioorg Med Chem Lett | 2024 | 38876177 | PubTator, text mining | PubMed |
| Discovery of a potent, orally available furopyridine derivative as a novel selective bromodomain and extra-terminal domain (BET)-first bromodomain (BD1) inhibitor. | Bioorg Med Chem Lett | 2024 | 38876176 | PubTator, text mining | PubMed |
| High-Frequency and High-Current Transmission Techniques for Multiple Earth Electrical Characteristic Measurement Systems Based on Adaptive Impedance Matching through Phase Comparison. | Sensors (Basel) | 2024 | 38793961 | PubTator, text mining | PubMed |
| Inferring B-cell derived T-cell receptor induced multi-epitope-based vaccine candidate against enterovirus 71: a reverse vaccinology approach. | Clin Exp Vaccine Res | 2024 | 38752008 | PubTator, text mining | PubMed |
| Discovery of indole-2-one derivatives as BRD4 (BD1) selective inhibitors. | Bioorg Med Chem | 2024 | 38749341 | PubTator, text mining | PubMed |
| The Relationship between Tumor Budding and Tumor Deposits in Patients with Stage III Colorectal Carcinoma. | J Clin Med | 2024 | 38731112 | PubTator, text mining | PubMed |
| Dectin-1/SYK Activation Induces Antimicrobial Peptide and Negative Regulator of NF-κB Signaling in Human Oral Epithelial Cells. | In Vivo | 2024 | 38688646 | PubTator, text mining | PubMed |
| Possible Impact of Human β-defensin 1 on sperm motility in infertile men with abnormal sperm parameters. | Reprod Biol | 2024 | 38688100 | PubTator, text mining | PubMed |
| Change in Tissue Microbiome and Related Human Beta Defensin Levels Induced by Antibiotic Use in Bladder Carcinoma. | Int J Mol Sci | 2024 | 38674148 | PubTator, text mining | PubMed |
| Human β-defensin-1 affects the mammalian target of rapamycin pathway and autophagy in colon cancer cells through long non-coding RNA TCONS_00014506. | World J Gastrointest Oncol | 2024 | 38660658 | PubTator, text mining | PubMed |
| Curcumin effects on age-related changes in oral immunity: an in vivo study. | Br J Nutr | 2024 | 38634264 | PubTator, text mining | PubMed |
| Drug repositioning for immunotherapy in breast cancer using single-cell analysis. | NPJ Syst Biol Appl | 2024 | 38589404 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1672/papers?page=8